Introduction
The urokinase-type plasminogen activator receptor (u-PAR), a 45-60 kDa glycosylated receptor (u-PAR) is a multifunctional protein that plays a central role in proteolysis, cell migration and growth control (Yebra et al., 1996; Aguirre-Ghiso et al., 2001) . The u-PAR contributes to these functions via diverse mechanisms. First, the serine protease urokinase bound to this receptor activates plasminogen faster than fluid-phase plasminogen activator thereby augmenting extracellular matrix degradation. Second, the u-PAR interacts with the extracellular domain of integrins thereby mediating cell adhesion and migration (Wei et al., 1994 (Wei et al., , 1996 . Thirdly, the u-PAR stimulates cell growth via epidermal growth factor (EGF) receptor-dependent and independent signaling (Liu et al., 2002; Jo et al., 2003) . Lastly, the seven-trans-membrane receptor N-formylpeptide receptor-like receptor-1/lipoxin A4 receptor directly interacts with a soluble cleaved form of u-PAR to induce chemotaxis (Resnati et al., 2002) .
In cancer, u-PAR expression has been implicated in tumor growth and progression and counters tumor dormancy (Aguirre-Ghiso et al., 2001) . Indeed, elevated u-PAR protein/messenger RNA (mRNA) levels are evident in various malignancies (Stephens et al., 1999; Nestl et al., 2001; Schaner et al., 2003) and correlate with growth (Liu et al., 2002) and tumor progression (Nestl et al., 2001) . In colon cancer, the u-PAR gene is expressed at invasive foci (Pyke et al., 1991) and high u-PAR protein levels predict a poor patient outcome (Ganesh et al., 1994; Stephens et al., 1999) . Moreover, interfering with u-PAR expression or function retards growth and invasiveness of some malignancies including colorectal cancer (Reiter et al., 1993; Rabbani and Gladu, 2002; Lakka et al., 2003) .
The amount of u-PAR protein is controlled mainly at the transcriptional level (Hapke et al., 2001; Trisciuoglio et al., 2004; Wang et al., 2004) although altered message stability (Shetty et al., 1997 (Shetty et al., , 2005 , translational efficiency (Mahoney et al., 2001 ) and receptor recycling (Nykjaer et al., 1997 ) also contribute to the quantity of this gene product. Multiple cis elements including stimulatory protein-1 (Sp1), polyoma enhancer A binding protein-3 (PEA3)/E twenty six (Ets), nuclear factor kappa B and Kruppel-like zinc-finger transcription factor (KLF4) recognition motifs (Soravia et al., 1995; Wang et al., 2000 Wang et al., , 2004 Hapke et al., 2001) residing in the upstream 1469 bp (base pairs) of the u-PAR gene regulates its expression in response to diverse biological cues including b3 integrin, bcl-2 and the KLF4. Post-translationally, the tumor metastases suppressor KAI1 (CD82) directs cell surface u-PAR to cryptic sites rendering it unable to bind urokinase (Bass et al., 2005) and hindering proteolysis.
In colon cancer, elevated u-PAR expression is driven at least in part through the Wnt pathway (Lengyel et al., 1996; Mann et al., 1999) and via a mutation-activated K-Ras oncogene (Allgayer et al., 1999b) . Equally important, a diverse set of growth factors including EGF and hepatocyte growth factor/scatter factor that signal through extracellular signal-regulated protein kinase/mitogen-activated protein kinase (McCawley et al., 1999) stimulate u-PAR expression (Lund et al., 1995; Jeffers et al., 1996) . However, we have observed that in several instances, the fold induction in expression of the endogenous u-PAR gene far exceeds that evident with transiently transfected reporter constructs driven by the 1469 bp of upstream regulatory sequence. Consequently, we speculated that regulatory elements, hitherto unknown, also contribute to u-PAR regulation.
We describe herein a novel intragenic enhancer residing in a chromatinized region of intron 1 ( þ 665/ þ 2068) of the u-PAR gene, enriched in histone 3 (H3) K4 methylation and acetylation, that contributes to constitutive and phorbol ester-dependent induction of transcription from the u-PAR promoter in colon cancer.
Results
H3K4me and H3ac marks a DNase I hypersensitive region in intron 1 of the u-PAR gene As our DNase I hypersensitivity assays had previously failed to identify additional putative regulatory region(s) up to -6 kb 5 0 of the transcriptional start site (Nair et al., 2005) and considering that some genes Palii et al., 2004) are regulated by intragenic elements, we questioned whether sequences 3 0 of the u-PAR transcription start site control its expression. Consequently, we first performed DNase I hypersensitivity assays using a colon cancer cell line (RKO) that constitutively transcribes the u-PAR gene (Lengyel et al., 1996) . Hypersensitive sites are indicative of relaxed chromatin regions and often are regulatory for expression. Isolated RKO nuclei were incubated with increasing amounts of DNase I and the DNA subsequently digested to completion with the Asp178/NruI restriction enzymes. DNA fragments were resolved and probed with a fragment spanning þ 143/ þ 318 of the u-PAR gene. A hypersensitive region extending approximately from þ 600 to þ 1300 in the u-PAR gene ( Figure 1 ) and residing within intron 1 (Casey et al., 1994) was evident for these constitutively u-PAR-expressing cells.
Histone H3 methylation at lysine 4 (H3K4me) and histone H3 acetylation (H3ac) often mark regulatory genomic regions (Liang et al., 2004) and to accrue further evidence for a role of the DNase I hypersensitive region in modulating u-PAR expression, we next employed chromatin immunoprecipitation to identify regions of the u-PAR gene enriched in these histone modifications. DNA-bound histones were cross-linked in RKO cells in vivo, DNA isolated and chromatin immunoprecipitated with antibodies directed at these modified histones. Purified DNA was then subjected to quantitative polymerase chain reaction (PCR) using a series of primers (Figure 2a ) to amplify fragments of the endogenous u-PAR gene corresponding to sequences located 5 0 (U1, U2, U3) or 3 0 (D1, D2) of the main transcriptional start site (Soravia et al., 1995) . Real-time PCR quantitation indicated a pronounced enrichment in DNA bound with H3K4me and H3ac amplified with the D1 ( þ 1017/ þ 1136) primer set derived from intron 1. In contrast, little enrichment in H3ac/H3K4me-bound DNA was evident with the D2 primer set amplifying a region of intron 3 ( þ 5762/ þ 5784) arguing against the possibility that the augmented binding of these modified Figure 1 DNase I hypersensitivity reveals a chromatin accessible region spanning þ 600/ þ 1300 in the u-PAR gene. Isolated nuclei from RKO cells were digested with increasing DNase I amounts (0-30 U), DNA purified and cleaved with Asp718/NruI. DNA fragments were resolved by gel electrophoresis, transferred to a filter and probed with a u-PAR genomic fragment spanning þ 143/ þ 318. The linear map to the left indicates the position of exons 1, 2 and intron 1. The data are typical of duplicate experiments.
An intragenic enhancer regulates u-PAR expression H Wang et al histones was merely an effect secondary to polymerase II read-through. An enrichment in these markers of open chromatin was also evident with the U3 primer set (À260/À172) corresponding to the upstream u-PAR regulatory region described previously (Lengyel et al., 1996) . In contrast, little enrichment of the DNA spanning upstream regions (À5839/À5722 and À2290/ À2190) was evident with the U1 and U2 primer sets, respectively, these regions showing no hypersensitivity (Nair et al., 2005) . Thus, colon cancer cells constitutively transcribing the u-PAR gene are characterized by a region of intron 1 decondensed in vivo and bound with markers (H3K4 me and H3ac) often associated with regulatory sequences (Liang et al., 2004) .
Requirement of the intron 1 ( þ 665/ þ 2068) sequence for u-PAR gene expression To determine the functional role of the intron 1 hypersensitive region enriched in markers of gene regulation, we sub-cloned a fragment þ 665 þ /2068 inclusive of this region into a luciferase reporter driven by 1469 bp of 5 0 flanking sequence of the u-PAR gene. This upstream region contains cis elements that contribute to constitutive and inducible u-PAR expression (Lengyel et al., 1996; Allgayer et al., 1999c; Wang et al., 2000 Wang et al., , 2004 Hapke et al., 2001) . The intron 1 fragment was inserted downstream of the transcriptional start site, akin to the natural position in the endogenous gene, and 3 0 of the polyadenylation site to preclude any confounding effects of splicing on data interpretation. The resulting luciferase reporter construct (À1469 u-PAR Luc þ 665/ þ 2068) or the corresponding reporter lacking the intronic fragment (À1469 u-PAR Luc) was then assayed in three independent colon cancer cell lines (RKO, 2C8, HCT 116) transcriptionally active for u-PAR expression (Lengyel et al., 1996; Allgayer et al., 1999a) . The þ 665/ þ 2068 fragment induced reporter activity in these 3 colon cancer cell lines albeit with varying potency. RKO cells demonstrated a >10-fold induction (Figure 3a ) whereas about a threefold increase in transcription from the u-PAR promoter was evident with the HCT 116 and 2C8 cells.
Activation of the c-raf-MAPK-kinase kinase (MEK)1/ 2-ERK signaling pathway by mutated K-Ras (prevalent in B40% of colorectal cancers (Ahnen et al., 1998) ) and growth factors (Lund et al., 1995; Jeffers et al., 1996) drives u-PAR expression Allgayer et al., 1999b) and as this signaling module is potently stimulated by phorbol 12-myristate 13-acetate (PMA) (Jones et al., 1994) , we determined whether the ability of the phorbol ester to augment transcription from the À1469 u-PAR promoter required the DNase I hypersensitive region. RKO cells transiently transfected with either the u-PAR promoter-luciferase construct (À1469 u-PAR Luc) or the corresponding plasmid including the hypersensitive region of intron 1 (À1469 u-PAR Luc þ 665/ þ 2068) were treated with, or without, the phorbol ester and assayed for reporter activity. Whereas only a minimal PMA-dependent stimulation of the À1469 u-PAR Luc reporter was evident (Figure 3b) , addition of the intron 1 fragment ( þ 665/ þ 2068) augmented sensitivity to the phorbol ester. Together, these data indicate that the chromatin-accessible þ 665/ þ 2068 fragment of the u-PAR gene is regulatory for both constitutive and phorbol ester-inducible expression of this gene.
We previously reported that the Kruppel-like transcription factor 4 (KLF4) induced u-PAR expression in colon cancer cells and directed u-PAR expression in the apical cells of the colonic crypt (Wang et al., 2004) . Interestingly however, the ability of transiently expressed KLF4 to increase transcription from the À1469 u-PAR promoter in RKO cells was not further augmented by inclusion of the þ 665/ þ 2068 sequence ( Figure 3c ). Thus, whereas KLF4 increased reporter activity driven by the 5 0 flanking sequence by B80%, inclusion of the hypersensitive region of intron 1 did not further potentiate this % increase.
The þ 665/ þ 2068 u-PAR fragment displays enhancer properties To determine the efficacy of the þ 665/ þ 2068 fragment with respect to orientation and distance, this fragment An intragenic enhancer regulates u-PAR expression H Wang et al was sub-cloned into the À1469 u-PAR promoter Luc construct in the anti-sense orientation. RKO cells transfected with the À1469 u-PAR Luc construct, or the corresponding construct bearing the intron 1 hypersensitive region cloned in either the sense or antisense orientation, were then assayed for reporter activity ( Figure 4a ). The reporter constructs harboring this intron 1 region, in either orientation were equiactive in these assays with both substantially (Beightfold) upregulating transcription from the À1469 u-PAR promoter.
Next, to assess the effect of distance on the efficacy of the H3ac/H3K4me-bound hypersensitive region in regulating u-PAR expression, the þ 665/ þ 2068 fragment was sub-cloned upstream of the 5 0 regulatory sequence (generating the þ 665/ þ 2068 -1469 u-PAR Luc construct). Although the intron 1 sequence augmented transcription from the u-PAR promoterdriven reporter approximately threefold in RKO cells (Figure 4b ), its activity was less than the construct (À1469 u-PAR Luc þ 665/ þ 2068) harboring the þ 665/ þ 2068 sequence cloned 3 0 of the transcriptional A region spanning þ 1028/ þ 1153 of the u-PAR gene is critical for enhancer activity A systematic analysis to determine the region of intron 1 responsible for enhancer activity was then undertaken by subcloning 3 0 truncated fragments of the þ 665/ þ 2068 sequence into the À1469 u-PAR Luc construct. Interestingly, deletion of the sequence residing between À2068 and À1350 yielded a somewhat stronger activity (Figure 5a ) in the reporter assays suggesting the presence of a weak silencing element(s). However, further 3 0 truncation yielded a progressive reduction in activity with the þ 665/ þ 998 sequence showing no augmentation of transcription. Thus, the intron 1 enhancer activity lies within the þ 998/ þ 1350 u-PAR genomic sequence. To refine this analysis, further truncations were generated (Figure 5b ). Whereas the þ 999/ þ 1153 sequence stimulated activity of the reporter over 10-fold, 3 0 truncation to the þ 1028 position generated a construct (À1469 u-PAR Luc þ 999/ þ 1028) that did not potentiate transcription from the u-PAR promoter. Thus, the enhancer activity of intron 1 requires the þ 1028/ þ 1153 sequence of the u-PAR gene.
DNase I footprinting and functional assays indicate 2 protected regions in the þ 1028/ þ 1153 sequence required for optimal transcription from the u-PAR promoter To identify transcription factor-bound cis elements in the þ 1028/ þ 1153 u-PAR genomic sequence, we performed DNase I footprinting using RKO nuclear extract. These experiments revealed (Figure 6 ) two clearly protected regions ( þ 1060/ þ 1099 and þ 1123/ þ 1134), presumably transcription factor-bound. To determine the requirement of these protected regions, we constructed reporter plasmids harboring the intron 1 derived þ 999/ þ 1153 sequence but internally-deleted of these aforementioned regions. Expectedly, the þ 999/ þ 1153 fragment (construct À1469 u-PAR Luc þ 999/ þ 1153) potently increased transcription from the u-PAR promoter (Figure 7) whereas deletion of the þ 1060/ þ 1099 footprinted region (construct -1469 u-PAR Luc þ 999/ þ 1153 (d1060-1099)) reduced enhancer activity by over 65%. Equally important, deletion of the þ 1123/ þ 1134 protected region (construct -1469 u-PAR Luc þ 999/ þ 1153 (d1121-1134)) nearly abolished enhancer activity indicating the critical requirement of this minimal sequence. Considering the dramatic effect of deleting these regions on enhancer activity, these two protected regions were queried (http://www.cbil.upenn.edu/cgi-bin/tess) for putative transcription factor binding sites. The þ 1060/ þ 1099 region contained candidate overlapping binding sites for c-enhancer-binding protein (EBP)a (1063/ þ 1068) and Sp1 (1067-1073) whereas the þ 1123/ þ 1134 sequence overlapped with sites (TGAGTaA) resembling activator protein-1 (AP-1) ( þ 1119/ þ 1125) and c-Ets-1(CActTCCGGG) ( þ 1126/ þ 1135) cis elements.
As deletion of the þ 1121/ þ 1134 sequence bearing putative AP-1/Ets binding sites, almost abolished enhancer activity (Figure 7 ) and because u-PAR expression in colon cancer, is driven via mutationactivated K-Ras-and Wnt signaling both converging on AP-1-dependent trans-activation of genes (Mann et al., 1999; Allgayer et al., 1999b) , mobility shift assays and chromatin immunoprecipitation assays were performed to identify transcription factor(s) bound to this sequence. Nuclear extract from RKO cells retarded the mobility of an oligonucleotide spanning this intron 1 sequence (Figure 8 lane 2-parenthesis) indicative of DNA-bound transcription factor(s) as the retarded bands were abolished with excess non-radioactive oligonucleotide (Figure 8 lane 7) . Addition of an antibody cross-reactive with c-Jun/JunD/JunB yielded a supershifted band (Figure 8 Lane 3-asterisk) at the expense of the DNA-protein complex (parenthesis). Similarly, an antibody recognizing c-Fos/FosB/Fra-1/ Fra-2 generated a slower migrating complex (Figure 8 Lane 4-asterisk) again at the expense of the shifted band (parenthesis). In contrast, a rabbit polyclonal antibody (sc-112 Santa Cruz (Santa Cruz, CA, USA) crossreactive with Ets-1 and Ets-2 failed to generate a ternary Figure 5 Deletion analysis of the u-PAR intron 1 enhancer. RKO cells were transiently transfected and assayed for luciferase activity as described in the legend to Figure 3a (Yang et al., 1996; Galang et al., 2004) . To determine if the endogenous þ 1121/ þ 1134 sequence of the u-PAR gene was bound with these AP-1 family member(s) we performed chromatin immunoprecipitation assays. Chromatin from RKO cells was immunoprecipitated with the pan-Jun and pan-Fos antibodies, and immunoprecipitated DNA then PCRamplified using primer sets (Figure 9a ) either spanning the putative AP-1 motif ( þ 1119/ þ 1125) (primer 1) or a downstream sequence, also in intron 1, but devoid of this binding site (primer 2). DNA spanning the intron 1 AP-1 motif ( þ 1119/ þ 1125) was enriched in c-Jun (and/or JunD/JunB) and c-Fos (and/or FosB/Fra-1/ Fra-2) (Figure 9a and b) whereas, little DNA enrichment was evident with primer 2 set ( þ 2258/ þ 2317) using the same antibodies. Quantitative PCR (Figure 9c ) of the immunoprecipitated chromatin from the RKO cells using the primer 1 pair indicated an approximate eightfold enrichment (relative to nonspecific immunoglobulin (IgG) of the DNA spanning the intron 1 AP-1 motif ( þ 1119/ þ 1125) with the pan-Fos antibody whereas a two-threefold enrichment was evident with the pan-Jun antibody. In contrast, and consistent with the data in Figure 9b , little amplified product, over background, was evident with primer 2 set subsequent to chromatin immunoprecipitation with these AP-1-directed antibodies (Figure 9c) . Together, these experiments indicate the importance of the AP-1-bound intron 1 sequence ( þ 1119/ þ 1125) for u-PAR enhancer activity.
In resected colon cancer, increased transcription factor binding to the þ 1123/ þ 1134 region is associated with elevated u-PAR protein levels U-PAR mRNA levels are elevated in resected colon cancers (Ganesh et al., 1994; Suzuki et al., 1999) and to An intragenic enhancer regulates u-PAR expression H Wang et al accrue evidence for a role of the u-PAR enhancer in driving elevated expression of this gene in this malignancy, we performed electrophoretic mobility shift assays (EMSA), as described previously (Schewe et al., 2003) , on a series of resected colon tumors (Figure 10 ). Incubation of nuclear extract derived from these tissues with the oligonucleotide ( þ 1111/ þ 1138) spanning the intron 1 region, critical for enhancer activity, gave rise to protein-DNA complexes (parenthesis) which, in the most part, were specific as they were abolished with excess non-radioactive oligonucleotide competitor. Importantly, nuclear extract generated with tumor (T) from patients 1, 2, 3, 5, 6, 8, 9, 10 and 13 yielded more intense bands (parenthesis-compare lanes 3 with 1, 7 with 5, 11 with 9, 19 with 17, 23 with 21, 31 with 29, 35 with 33, 39 with 37, and 51 with 49, respectively) when compared with nuclear extract derived from the matched non-malignant mucosa (N) and these observations paralleled a twofold, or more, increase in u-PAR protein levels in the former tissue as measured by enzyme-linked immunosorbent assay (ELISA). Nuclear extract from patients 4, 7 and 11 also produced retarded bands, but were comparable in intensity for the tumor and non-malignant tissue. In these patients, elevated u-PAR expression could (i) reflect activity (Young et al., 2002) , rather than amount, of the bound AP-1 transcription factors (ii) be enhancer-independent or (iii) be a consequence of post-transcriptional control.
Discussion
The urokinase receptor, overexpressed in several malignancies including colon cancer, contributes to tumor progression. Elevated u-PAR expression in this cancer is largely at the transcriptional level (Wang et al., 1994; Allgayer et al., 1999a) and we report, herein, a histone H3ac-and H3 K4me-bound chromatin-accessible enhancer residing in intron 1 required for both constitutive and phorbol ester-inducible expression of the u-PAR gene.
We had previously identified KLF4, a zinc-finger transcription factor, as a novel regulator of u-PAR expression (Wang et al., 2004) driving u-PAR expression in the apical cells of the colonic crypt. However, our current study shows that optimal transcription (defined as % increase) from the u-PAR promoter, in response to this transcription factor, does not require the intron 1 enhancer. Perhaps, this is not unexpected as computer Figure 8 Binding of AP-1 transcription factors to the intron 1 enhancer region. RKO nuclear extract was incubated with a radioactive oligonucleotide spanning þ 1111/ þ 1138 of the u-PAR gene with, or without, a 100-fold excess of non-radioactive oligonucleotide. The indicated antibodies were added to the nuclear extract before oligonucleotide addition. DNA-bound proteins were resolved by electrophoresis. The experiment was performed at least twice.
An intragenic enhancer regulates u-PAR expression
H Wang et al analysis indicated the intron 1 enhancer to be devoid of KLF4-binding motifs (Shields and Yang, 1998) . One ramification of our findings is that it may be possible to pursue strategies to repress u-PAR expression in colon cancer via targeting of the intron 1 enhancer without affecting KLF4-driven u-PAR expression in the normal colonic crypt. The u-PAR intron 1 enhancer varied in strength in the different u-PAR-expressing colon cancer cells. Although transcription from the u-PAR promoter was strongly Figure 10 Nuclear extract from resected colon cancers shows increased binding to the intron 1 sequence critical for enhancer activity coordinate with elevated u-PAR protein levels. EMSA was performed as described for Figure 8 using an oligonucleotide spanning þ 1111/ þ 1138 of the u-PAR gene and nuclear extract generated from resected colorectal cancers. N and T indicate non-malignant adjacent mucosa and tumor tissue, respectively. An ELISA determined the u-PAR protein amount in the tissue. The presence/absence of oligonucleotide competitor is indicated with þ /À, respectively.
An intragenic enhancer regulates u-PAR expression H Wang et al augmented (eight-30-fold) in RKO cells, HCT 116 and 2C8 cells displayed a lower dependence on the enhancer (Bthreefold increase). Interestingly, GEO cells, transcriptionally induced for u-PAR expression by phorbol ester (Lengyel et al., 1996) , showed little requirement for the enhancer (data not shown). These findings parallel our observations with nuclear extract from resected colon cancers in that increased DNA-protein binding to the þ 1111/ þ 1138 intron 1 sequence was evident in most, but not all, of the cancer tissues characterized by their elevated u-PAR protein. Together, these findings suggest that multiple inputs, one represented by the enhancer, contribute to elevated u-PAR transcription. Another possibility is that the transcriptional activity of DNA-binding factors recruited to this region or co-activator/repressor association with the bound transcription factors differs for the different colon cancer cells/tumor tissue culminating in varying contribution of this region to u-PAR gene expression.
What might be the contribution of the intron 1 enhancer in driving elevated u-PAR expression in response to signaling pathways commonly activated in colon cancer? In this malignancy, a mutation-activated K-Ras is evident in approximately 40% of colorectal cancers (Bos, 1989; Ahnen et al., 1998) and this oncogene increases u-PAR synthesis (Allgayer et al., 1999b) . Interestingly, HCT 116 cells, harboring a mutation-activated K-Ras (Shirasawa et al., 1993) showed a clear requirement for the enhancer for optimal transcription from the u-PAR promoter. Further, the intronic enhancer augmented PMA-dependent transcription from the u-PAR promoter a pertinent finding as mutation-activated K-Ras connects to the nucleus partly through the well-defined c-raf-MEK/-ERK module (Robbins et al., 1992) the later activated by the phorbol ester (Sozeri et al., 1992) . On the other hand, RKO cells showing the greatest enhancer activity are wild type for K-Ras (Russo et al., 2002) . Nevertheless, ERKs1/2, required for u-PAR expression , are intrinsically activated in these cells, as well as in models of colon cancer progression (Licato et al., 1997) and more than likely, the enhancer activity in RKO cells reflects common signaling through this module. Like K-Ras, Wnt pathway activation is prevalent in colon cancer either via adenomatous polyposis coli (APC) or b-catenin mutations (Shitoh et al., 2001; Radtke and Clevers, 2005) and induces u-PAR expression over 10-fold (Mann et al., 1999) albeit indirectly via increased c-Jun and Fra-1 synthesis (Mann et al., 1999) . Again, the intron 1 enhancer, the activity of which is dependent on an AP-1-spanning sequence bound with endogenous c-Jun (and/or the related JunD/JunB) and c-Fos (and/or the related FosB/ Fra-1/Fra-2) may very well contribute to the augmented u-PAR gene expression subsequent to Wnt pathway activation evident in this malignancy.
The two DNase I footprinted regions þ 1060/ þ 1099 and þ 1123/ þ 1134 in intron 1, required for enhancer activity, contained c-EBPa/Sp1 and a non-consensus AP-1 element, respectively, the latter bound in vivo with the c-Jun (and/or JunB/JunD) and c-Fos (and/or FosB, Fra-1/Fra-2). Interestingly, the upstream regulatory sequence of the u-PAR gene also bear well-characterized Sp1 and AP-1 motifs (Lengyel et al., 1996; Allgayer et al., 1999c) raising the question as to the redundancy of these elements. Certainly, the upstream AP-1 binding site is required for u-PAR induction by phorbol ester (Lengyel et al., 1996) and a mutation-activated K-Ras (Allgayer et al., 1999b) and, likewise, the Sp1 motifs contribute to the elevated expression of this gene achieved with a constitutively active Src protein kinase (Shanahan et al., 1999) . One possibility is that, like the b-globin gene, these motifs bound with AP-1 family members and brought together by DNA looping (Kleinjan and van Heyningen, 2005) , recruit co-activators such as BAF60a (Ito et al., 2001) , Brg-1 (Ma et al., 2004) or steroid receptor coactivator-1 (SRC-1) (Lee et al., 1998) yielding optimal u-PAR expression in response to biological cue(s). Alternatively, a long-range interplay may be operative where Sp1 binding increases c-Jun occupation at the AP-1 motif as evident at the CD11 promoter (Noti et al., 1996) .
Regulation of gene expression by intragenic sequences is rare, but not unprecedented. Like u-PAR, the prostaglandin H synthase gene is GC-rich and TATAless, and phorbol-ester-dependent transcription is markedly increased by a 100 nucleotide sequence in intron 8 (Delong and Smith, 2005) . Similarly, upregulated expression of the system A amino-acid transporter cued by amino-acid deprivation also requires an intron 1 nucleotide sequence and, like u-PAR, this sequence shows classical enhancer properties (Palii et al., 2004) .
In summary, we have identified a novel chromatinaccessible and H3ac-/H3K4me-bound intron 1 enhancer required for constitutive and phorbol ester-inducible expression of the u-PAR gene. This intron 1 enhancer may represent a common, termination point for disparate signaling pathways (activated K-Ras and Wnt signaling) leading to induced u-PAR gene expression.
Materials

Constructs
The À1469 u-PAR Luc construct has been described before (Wang et al., 2004) . The u-PAR intron 1 fragment ( þ 665/ þ 2068) was generated by PCR using Pfu-Turbo using the cosmid R28316 harboring the genomic sequence. Unless indicated otherwise, genomic fragments were inserted at the BamH1 site downstream of the luciferase coding sequence and following the polyadenylation site in the À1469 u-PAR Luc construct. Reporter constructs harboring 3 0 deleted fragments of the hypersensitive region were generated by PCR using Pfu-Turbo and the À1469 u-PAR Luc plasmid as template. For upstream studies, the þ 665/ þ 2068 genomic sequence was subcloned into the À1469 u-PAR Luc construct at the MluI site 5 0 of the À1469 promoter. Fragment orientation was checked by PCR and DNA sequencing. Internal deletions (constructs: À1469 u-PAR Luc þ 999/ þ 1153 (d1060-1099) and À1469 u-PAR Luc þ 999/ þ 1153 (d1121-1134)) were generated by PCR (18 cycles) using Pfu Turbo, the -1469 u-PAR Luc þ 999/ þ 1153 construct as template, and primers designed to remove the indicated region. Following PCR, the amplified fragment was re-ligated.
Chromatin immunoprecipitation assays
These assays were performed essentially as described previously (Yan et al., 2003) but with modifications. After cell lysis, cross-linked chromatin was sonicated, and incubated with 1 mg of antibodies at 41C overnight. Antibodies directed against methylated H3 at K4 (#05-791) and acetylated H3 at K9/K14 (#06-599) were from Upstate (Charlottesville, VA, USA), and antibodies against pan-Jun (#sc44) and pan-Fos (#sc253) were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The immuno-complex was precipitated with protein A-agarose, beads washed, sequentially treated with 10 mg of RNase A (371C for 30 min) and 75 mg of proteinase K (451C for 4 h), and incubated at 651C overnight to reverse chromatin cross-links. The DNA was recovered by phenol/chloroform extractions, coprecipitated with glycogen, and dissolved in 50 ml of Tris ethylenediaminetetraacetic acid (EDTA) (TE) buffer for real-time PCR assays.
DNA amounts were quantitated with real-time PCR as described previously (Yan et al., 2003) . Primers amplifying the indicated DNA regions of the u-PAR gene were designed based on the genomic sequence (www.genome.uscs.edu) and are as follows with their indicated genomic position relative to the main transcriptional start site: U1 (À5839/À5722), ACAG CAACCGAAGAACAAGGAC-3 0 and 5 0 -GTGTTCT CTGAAGGCAACTGTGTG-3 0 ; U2 (À2290/À2190), 5 0 -GCAAGTGGCATTCAAGCAGA-3 0 , and 5 0 -AGGC CTTTGCACTGGTTGTT-3 0 ; U3 (À260/À172), 5 0 -GG GTCCCACGTTAGGAAGAG-3 0 and 5
0 -GACTTGTGGGCAGGGATA GA-3 0 and 5 0 -CCGTTGTCCACGTTCTACCT-3 0 ; Melting curves were performed at the end of each quantitation with a single peak indicative of amplification of a unique product.
DNase I footprinting Preparation of nuclear extracts and DNase I footprinting were performed essentially as previously published ). An end-labeled u-PAR genomic fragment ( þ 1029/ þ 1220) (0.3 ng) was incubated with poly (dI-dC), nuclear extract and transcription buffer (20 mM N-2-hydroxyethylpiperazine-N 0 -2-ethanesulfonic acid (HEPES), 100 mM KCl, 2 mM EDTA, 5 mM MgCl2, 1.5 mM dithiothreitol (DTT)) for 15 min (room temperature) after which DNase I (final concentration ¼ 2-10 mg/ml) was added. A stop solution (10 mM EDTA, 0.1% sodium dodecyl sulfate (SDS), and 50 mg/ml of proteinase K) was added 30 s later. After 30 min at 371C, the mixture was extracted with phenol/ chloroform, precipitated, washed with 70% ethanol and dried. The material was dissolved in denaturing solution containing formamide and electrophoresed in a DNA sequencing gel. Generation of G and G þ A ladders was as described previously by this laboratory (Lengyel et al., 1996) .
DNaseI hypersensitivity assays These were performed as described elsewhere (IbanezTallon et al., 1999) . Logarithmic cells were re-suspended in hypotonic buffer (10 mM Hepes pH 7.4, 10 mM KCl, 0.1 mM EDTA, 0.1 mM ethyleneglycoltetraacetate (EGTA), 0.75 mM spermidine, 0.15 mM spermine, 1 mM DTT). Cells were collected by centrifugation and re-suspended in the same buffer for 5 m at 41C. Nonidet P-40 was added (final concentration ¼ 0.5%) and incubated for an additional 5 min. Nuclei were re-suspended in DNaseI reaction buffer (15 mM Hepes, pH 7.6, 60 mM KCl, 15 mM NaCl, 0.1 mM EGTA, 0.05 mM CaCl 2 , 320 mM sucrose, 0.5 mM phenylmethylsulfonyl fluoride, 0.5 mM DTT, 0.5 mM spermidine and 0.15 mM spermine) and varying DNaseI amounts added. MgCl 2 (5 mM-final concentration) was added and after 15 min at 371C, reactions stopped with 2.5% (w/v) sodium lauryl sarcosine/100 mM EDTA. RNase A was added (1 h at 371C) followed by SDS and proteinase K (final concentrations ¼ 0.5% (w/v) and 0.5 mg/ml, respectively). After an overnight incubation (371C), samples were extracted with phenol:chloroform:isoamyl alcohol (25:24:1), precipitated, and re-suspended in TE. Purified DNA was cut with Asp718/NruI, digested fragments resolved by electrophoresis and probed with a radioactive u-PAR promoter fragment.
ELISA to determine u-PAR protein amounts
The amount of u-PAR protein in the colon tissue was assayed using Imubind-u-PAR-ELISA kit (American Diagnostica, Greenwich, CT, USA) as per the manufacturer's instructions.
Mobility shift assays
Nuclear extract preparation and EMSA were performed as described previously (Wang et al., 2004) with the exception that resected tissue specimens, snap-frozen in liquid nitrogen, were mechanically pulverized. Nuclear extracts (5-10 mg) were incubated in a buffer (25 mM HEPES (pH 7.9), 0.5 mM EDTA, 0.5 mM DTT, 0.05 M NaCl, 4% (v/v) glycerol) with a [ 32 P] ATP end-labeled oligonucleotide spanning region þ 1111/ þ 1138 of the u-PAR gene for 20 min in the absence or presence of a 100-fold excess of unlabeled oligonucleotide. A total of 0.5 mg of poly(dI-dC) was included in each reaction to block nonspecific binding. DNA-bound complexes were resolved by gel electrophoresis and visualized by exposure to Kodak MR film.
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Reporter assays
Reporter assays were performed as described previously (Wang et al., 2004) . Cells were co-transfected (using Lipofectamine 2000) with a u-PAR promoter-driven luciferase reporter (0.2 mg) and, where indicated, an expression vector (pcDNA 3.1) encoding KLF4 (3-30 ng) (Wang et al., 2004) . Transfections included 0.03 ng of a b-actin-regulated Renilla luciferase reporter to normalize for varying transfection efficiencies. Cells were lysed and assayed for dual-luciferase activity 24 h later.
